Back to Journals » International Journal of Nanomedicine » Volume 19

Toxoplasma Gondii-Derived Exosomes: A Potential Immunostimulant and Delivery System for Tumor Immunotherapy Superior to Toxoplasma Gondii [Corrigendum]

Authors Zhao LX, Sun Q, Wang C, Liu JJ, Yan XR, Shao MC, Yu L, Xu WH , Xu R

Received 18 December 2024

Accepted for publication 18 December 2024

Published 27 December 2024 Volume 2024:19 Pages 14019—14020

DOI https://doi.org/10.2147/IJN.S513024



Zhao LX, Sun Q, Wang C, et al. Int J Nanomedicine. 2024;19:12421—12438.

Page 12423, line 9, the text “by inducing macrophage polarization and stimulating T cells.38,39” should read “by stimulating macrophage and T cells.83”.

Page 12429, lines 1-3, the sentence “Another study revealed that T. gondii secretes exosomes after host invasion, and the exosomes present T. gondii antigens to T cells either directly or via antigen-presenting cells, which activate T cells and immune responses.39” should be removed.

Page 12435, References section, the following references should be removed from the reference list.

38. Schorey JS, Cheng Y, Singh PP, Smith VL. Exosomes and other extracellular vesicles in host-pathogen interactions. EMBO Rep. 2015;16:24–43. doi:10.15252/embr.201439363

39. Théry C, Duban L, Segura E, Véron P, Lantz O, Amigorena S. Indirect activation of naïve CD4+ T cells by dendritic cell-derived exosomes. Nat Immunol. 2002;3:1156–1162. doi:10.1038/ni854

The authors apologize for these errors.


Read the original article


Creative Commons License © 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, 3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.